Using an NF2 knockout mouse mammary tumor model, a study showed that these NF2-silenced cells had reduced activity of the nuclear factor erythroid 2, like 2 antioxidant transcription factor and increased expression of NADPH oxidases. This evidence concerns the gene FMO5 and breast cancer.